SEC Form 4 · accession 0001209191-19-019068
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Stein
Officer — President & CEO · Director
Period of report
Feb 26, 2019
Accepted (ET)
Mar 13, 2019 · 12:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | G | 21,340 | $0.00 | D | 173,119 | I | By trust |
| Common Stock | Feb 26, 2019 | G | 10,670 | $0.00 | A | 15,709 | I | By son |
| Common Stock | holding | — | — | — | 268,320 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involved a gift of securities by the reporting person to his sons, one of which is economically dependent on the reporting person. The reporting person disclaims beneficial ownership of the shares held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.